Videos

Västra Hamnen Möter

Medimi presents Q4 2024

Crunchfish presents Q4 2024

Västra Hamnen Möter - Nexam Chemical Holding

Västra Hamnen Möter - Xintela

Västra Hamnen Möter - Nasdaq

Västra Hamnen Möter - Inwido

Västra Hamnen Möter - Neola Medical

Crunchfish's CEO on the new approach

Västra Hamnen Möter - BPC Instruments

Västra Hamnen Möter - Safeture

Västra Hamnen Möter - SenzaGen

Crunchfish comments on Q1 2025

Västra Hamnen Möter - Shape Robotics

Västra Hamnen Möter - Spago Nanomedical

Västra Hamnen Möter - Advenica

Västra Hamnen Möter - Clemondo Group

Västra Hamnen Möter - Arrow Lake

Västra Hamnen Möter - OptiCept Technologies

Västra Hamnen Möter - Precise Biometrics

Crunchfish comments on Q3 2025

Västra Hamnen Möter - Charlotta Falvin

Medimi presenterar Q4 2024

Crunchfish om Q4 2024

aXichem on aXivite's market opportunities

Bioextrax presenterar Q3 2025 

Västra Hamnen Möter - Minesto

Nyheter

Bioextrax presenterar Q2 2025 

Crunchfishs vd om den nya approachen

Västra Hamnen Corporate Finance initierar bevakning av Precise Biometrics

Västra Hamnen Möter - I Love Lund

Interview with Precise Biometrics

Precise Biometrics about Q1 2025

Crunchfish kommenterar Q1 2025

Västra Hamnen Corporate Finance initierar bevakning av Gabather

Västra Hamnen Möter - 4C Strategies

Precise Biometrics about Q2 2025

Crunchfish kommenterar Q3 2025

Västra Hamnen M&A - Tilläggsköpeskilling

Västra Hamnen Möter - Lyckegård Group

Västra Hamnen M&A - Buddagen

Västra Hamnen Corporate Finance initierar bevakning av USWE

Västra Hamnen Möter - Mellby Gård

Precise Biometrics about Q3 2025

Bioextrax presents Q3 2025

Intervju med Precise Biometrics om Q3 2025

News

Intervju med Precise Biometrics vd 

Bioextrax presents Q2 2025

Västra Hamnen Möter - Trelleborg

Slutförda uppdrag

Precise Biometrics om Q12025

Västra Hamnen Möter - Clemondo

Västra Hamnen Möter - Jim Roslund

Crunchfish comments on Q2 2025

Västra Hamnen Meets

Västra Hamnen M&A - Earnouts

Västra Hamnen Meets - OptiCept Technologies

Västra Hamnen Meets - SenzaGen

Västra Hamnen Meets - Spago Nanomedical

Västra Hamnen Möter - Bengt Kjell

Västra Hamnen Meets - Nexam Chemical Holding

Precise Biometrics om Q2 2025

Företrädesemission - Crunchfish 2024

Västra Hamnen Meets- BPC Instruments

Västra Hamnen Meets - Neola Medical

Gabather comments on Q2 2025

Västra Hamnen Meets - Safeture

Västra Hamnen Meets - Clemondo

Västra Hamnen Möter - Örjan Johansson

Västra Hamnen Möter - Windon Energy Group

Västra Hamnen M&A - UDI with Fram Advokatbyrå

Västra Hamnen Meets - Gasporox

Västra Hamnen M&A - Due Diligence

Västra Hamnen M&A - the bidding day

Gabather comments on Q3 2025

Crunchfish kommenterar Q2 2025

Gabather - bolagspresentation i samband med TO7 2025

Gabather kommenterar Q2 2025

Ongoing transactions

Gabather comments on TO7 2025

Västra Hamnen Möter - Gasporox

Services

Transactions

About us

Contact

Here is more information about Västra Hamnen Corporate Finance's services.

Here you will find information about Västra Hamnen Corporate Finance's ongoing and completed transactions.

Here you will find more information about Västra Hamnen Corporate Finance.

Here, Västra Hamnen Corporate Finance's information for investors is gathered.

Investor relations

Västra Hamnen Corporate Finance

Precise Biometrics comments on Q3 2025

Precise Biometrics comments on Q2 2025

Precise Biometrics comments on Q1 2025

Despite lower sales, Precise Biometrics (Precise) reported a positive EBITDA for the quarter of MSEK 4.4. Revenue came in at MSEK 20.0 and costs decreased to MSEK 15.8.

Precise Biometrics: Lower growth, better profitability

Precise Biometrics reported their recent Q2 figures slightly below our expectations. The result was primarily affected by negative currency effects, a renegotiated customer contract, and longer sales cycles in a still uncertain market. Even with our revised projections, we maintain a fair value of SEK 7.25 per share. After a weak first half, the company now needs to demonstrate that growth will accelerate in the second half of 2025 and that it truly is a growth company.

Precise Biometrics: Market uncertainty slows Q2

The reported figures in Precise Biometrics' recent Q1 report were below our expectations. There are three main factors behind this: currency headwinds, the effect of a renegotiated customer contract, and cautiousness among customer during an uncertain period. Despite a bleak report and downward revisions for 2025 we remain optimistic in the long run, which is reflected in the unchanged fair value. 

Precise Biometrics: Headwind in Q1

Precise Biometrics is a Lund-based company that develops software for biometric recognition in various applications. 2024 was a turnaround year for Precise Biometrics, reporting a steady improvement in profitability. The stock market noted the development, Precise Biometrics was the best-performing share on the Swedish main list last year, posting a 350-per cent rise. Our growth prospects imply a fair value of SEK 7.25 per share.

Precise Biometrics

Analysts

Tobias Karlsson

Jacob Murat

Initial analysis

Precise Biometrics: Scanning for higher growth

Research updates

Related Videos